This trial will compare the effects of two types of nerve blocks on post-operative pain for patients undergoing ACL reconstruction.
- Postoperative Pain
- Anterior Cruciate Ligament Injury
1 Primary · 3 Secondary · Reporting Duration: up to two months after surgery
Awards & Highlights
2 Treatment Groups
Adductor Canal Block (ACB) Only
1 of 2
ACB + iPACK
1 of 2
82 Total Participants · 2 Treatment Groups
Primary Treatment: Adductor Canal Block (ACB) Only · No Placebo Group · Phase 4
Who is running the clinical trial?
Age Any Age · All Participants · 0 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Has the FDA authorized Adductor Canal Block (ACB) for clinical use?
"There is an abundance of clinical data supporting the safety of Adductor Canal Block (ACB), leading to a score of 3 on our scale. This treatment has already been approved for medical use, rendering it in Phase 4 trials." - Anonymous Online Contributor
What is the current patient intake for this clinical trial?
"Affirmative. Clinicaltrials.gov documents demonstrate that this clinical trial is currently enrolling individuals, with a first posting date of July 27th 2022 and a most recent edit on August 10th 2022. The study necessitates 82 participants across 1 site." - Anonymous Online Contributor
Are there opportunities for new participants to join this experiment?
"As per the data hosted on clinicaltrials.gov, this medical trial is proceeding and actively looking for candidates to participate. The study was first published on July 27th 2022 with a recent update occurring in August 10th of that same year." - Anonymous Online Contributor